SYSTEMIC
HYPERTENSION
Hemodynamic Comparison of Two Nifedipine Formulations in Patients with Essential Hypertension Edward D. Frohlich, MD, Mario J. McLaughlin, MD, Christoph J. Losem, MD, Reinhard Ketelhut, MD, and Franz H. Messerli, MD
The hemodynamic and humoral effects and trough-to-peak 24-hour blood pressure responses of 2 nifedipine formulations, capsules and continuous-release once-daily formulation tablets, were evaluated in 10 patients with mild to moderate essential hypertension. Roth formulations reduced mean arterial pressure similarly from 120 f 3 (baseline) to 107 f 2 (p
HYPERTENSION
Hemodynamic Comparison of Two Nifedipine Formulations in Patients with Essential Hypertension Edward D. Frohlich, MD, Mario J. McLaughlin, MD, Christoph J. Losem, MD, Reinhard Ketelhut, MD, and Franz H. Messerli, MD
The hemodynamic and humoral effects and trough-to-peak 24-hour blood pressure responses of 2 nifedipine formulations, capsules and continuous-release once-daily formulation tablets, were evaluated in 10 patients with mild to moderate essential hypertension. Roth formulations reduced mean arterial pressure similarly from 120 f 3 (baseline) to 107 f 2 (p
